Novel Cell Cycle Regulation in Triple Negative Breast Cancer

Novel Cell Cycle Regulation in Triple Negative Breast Cancer

Novel Cell Cycle Regulation in the Initiation and Therapeutic Intervention of Triple Negative Breast Cancer.


Dr. Lisa Porter

University of Windsor

Dr. Caroline Hamm

Windsor Regional Hospital

The project uses a mouse model, human cells, and patient samples to determine whether Spy1 and related proteins provide a signature to identify triple negative breast cancer patients who will respond to specific treatments. The project also addresses whether targeting Spy1 represents a valuable therapeutic direction for patients with this form of aggressive breast cancer.

Related Programs:
Nucleus Cores:

FUNDER:

CIHR

GRANT DURATION:

2015-2021

Loading...